LexDanaLexDanabeta
Inventor

JINGJING XIE

Inventor
US

Overview

2→
Patents
2022–2026
Patent span
Human necessities
Primary field (CPC A)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes22%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%
C07KPeptides22%
G01NInvestigating or analysing materials by determining their chemical or physical properties22%
C12NMicroorganisms or enzymes11%
PatentTitleYear
12,596,122LILRB2 antibodies and uses thereof202611,377,491Anti-leukocyte-associated immunoglobulin-like receptor 1 (LAIR1) monoclonal antibodies and method of use thereof to treat cancer2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022Patents assigned to UNIV TEXAS (1)· patent assignee history
2022–2026Based in US· patent location history
2026Patents assigned to IMMUNE ONC THERAPEUTICS INC (1)· patent assignee history
2026Patents assigned to THE BOARD OF REGENTS OF THE UNIV OF TEXAS SYSTEM (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
IMMUNE ONC THERAPEUTICS INC12026
THE BOARD OF REGENTS OF THE UNIV OF TEXAS SYSTEM12026
UNIV TEXAS12022
Locations
LocationPatentsSpan
US22022–2026